T-DXd for HER2-Low BC: Analysis Confirms Adverse Effects

A safety analysis following a landmark randomized phase 3 trial confirms that vomiting and nausea are quite common in patients who take the drug trastuzumab deruxtecan (T-DXd; Enhertu) to treat HER2-low metastatic breast cancer. Interstitial lung disease (ILD) also remains a concern, and it’s not clear if retreatment after resolution is warranted. In general, however, “T-DXd

Surprisingly simple ways to help prevent dementia

Surprisingly simple ways to help prevent dementia: A cuddle with a dog, working out sums in your head and eating a few pieces of dark chocolate every day… READ MORE: Is your memory loss usual for your age or is it a sign of dementia? From eating a few squares of dark chocolate every day to

The crisis is officially ending, but covid confusion lives on

The host Julie Rovner KFF Health News@jrovner Julie Rovner is chief Washington correspondent and host of KFF Health News' weekly health policy news podcast, "What the Health?" A noted expert on health policy issues, Julie is the author of the critically praised reference book "Health Care Politics and Policy A to Z," now in its

Class Acts 2023: Alexandra Zdonczyk

As a kid, one of Alexandra Zdonczyk’s favorite activities was discovering and observing small creatures in her backyard, and in streams and tidepools. She envisioned herself growing up and studying insects, birds or marine life. In high school, she became fascinated with human biology and imagined careers in medicine. Even so, Zdonczyk never saw herself

Simplifying Diagnosis of Rejection After Kidney Transplant

An automated system for the diagnosis of rejection after kidney transplant simplifies the assessment of increasingly complex criteria, significantly reducing the common occurrence of misclassification and potentially improving outcomes, according to new research. “To date, no study in transplantation and other medical fields has developed and validated an automated multimodal disease classification,” report the French authors

Potential Weight-Loss Drug Meets Goals in Midstage Trial

FRANKFURT (Reuters) – Denmark’s Zealand Pharma and Boehringer Ingelheim said their experimental obesity treatment achieved up to 14.9% weight loss in a mid-stage trial, lining up a potential contestant in the booming obesity drug market. In a statement on Wednesday, the partners said that the Phase II dose-finding trial met its primary endpoint of weight

Adults with sleep apnea may have higher risk of developing long COVID

Among people who have had COVID-19, adults with obstructive sleep apnea were more likely to experience long-term symptoms suggestive of long COVID than those without the sleep disorder, according to a large study supported by the National Institutes of Health (NIH). In fact, multiple analyses of electronic health records (EHR) uncovered adults with sleep apnea

Mosquitoes are more attractive to certain kinds of soaps, study finds

New research analyzes the interplay between soap scent, the body’s unique odor profile, and mosquito attraction. Researchers say coconut-scented soaps were among the most effective at repelling mosquitoes. Researchers would like to further explore why mosquitoes are drawn to certain chemicals in soap. Experts note that no soap is as effective as a proper mosquito

Alzheimer’s May Be Next Frontier for Drugs Like Ozempic

LONDON (Reuters) – Diabetes drugs that also promote weight loss such as Novo Nordisk’s Ozempic, becoming a darling of celebrities and investors, are being studied to tackle some of the most difficult-to-treat brain disorders, including Alzheimer’s disease. Diabetes regimens, from Ozempic to old mainstays like insulin and metformin, appear to address several different aspects of

Launching Revvity: A Scientific Solutions Company Powering Innovation from Discovery to Cure

Revvity, Inc. officially launches today as a science-based solutions company that leverages innovation across life sciences and diagnostics to help improve lives everywhere. Born from two words, “revolutionize” (rev) and “vita” (vit) meaning “life” in Latin, Revvity delivers end-to-end expertise and solutions from research discovery to development, and diagnosis to cure. The Company was previously affiliated

Change in breast density over time linked to cancer risk

Many middle-aged and older women get mammograms every one to two years to screen for breast cancer, as recommended by their doctors. A study by researchers at Washington University School of Medicine in St. Louis indicates that previous mammograms hold underutilized data that could help identify women at high risk of breast cancer and even

Experts urge increased attention to the threat of climate change and pollution on children's health

A new paper published in the Global Pediatrics Journal explores the impact of climate change and environmental chemicals that disrupt endocrine function on children's health. Study: The effects of climate change and exposure to endocrine disrupting chemicals on children's health: a challenge for pediatricians. Image Credit: Tartila/Shutterstock.com Background The last few decades have witnessed multiple crises involving